Fallopian tube carcinoma
MONDO:0006206A carcinoma that arises from epithelial cells of the fallopian tube.
Also known as: cancer of fallopian tube, cancer of the fallopian tube, fallopian tube cancer, carcinoma of fallopian tube, carcinoma of the fallopian tube, fallopian tube carcinoma
3019 clinical trials for this condition and its sub-types, 126 tagged with Fallopian tube carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Fallopian tube carcinoma
-
Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types
5 sub-types
- Fallopian tube serous adenocarcinoma 71 trials
- Fallopian tube endometrioid adenocarcinoma 30 trials
- Fallopian tube clear cell adenocarcinoma 18 trials
- Fallopian tube mucinous adenocarcinoma 9 trials
- Fallopian tube papillary adenocarcinoma 0 trials
-
Fallopian tube carcinosarcoma 8 trials
-
Hereditary fallopian tube carcinoma 0 trials
-
Ovarian cancer combo trial halted early
Disease control Stopped earlyThis study tested a new drug, CRLX101, combined with standard chemotherapy (paclitaxel) in 30 women with ovarian cancer that came back or didn't go away. The goal was to find the safest dose and see if the combination helped shrink tumors. The trial was terminated early, so resul…
Phase 1/2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental immune cell therapy targets Hard-to-Treat cancers
Disease control Stopped earlyThis early-phase trial tested a personalized cell therapy called ITIL-306 in people with advanced ovarian, lung, or kidney cancers that had not responded to standard treatments. The therapy uses a patient's own immune cells (TILs) taken from their tumor, modified to better attack…
Phase 1 • Sponsor: Instil Bio • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Measles virus takes on ovarian cancer in early trial
Disease control Stopped earlyThis phase 2 trial tested a genetically modified measles virus (MV-NIS) against standard chemotherapy in 17 women with ovarian, fallopian, or peritoneal cancer that no longer responded to platinum drugs. The virus was designed to infect and kill cancer cells while leaving healthy…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC